These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18949378)

  • 1. Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices.
    Kawaguchi T; Taniguchi E; Itou M; Ibi R; Okada T; Mutou M; Shiraishi S; Uchida Y; Otsuka M; Umeki Y; Oriishi T; Hayabuchi H; Tanaka S; Takakura M; Sata M
    Int J Mol Med; 2008 Nov; 22(5):589-94. PubMed ID: 18949378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites.
    Pirlich M; Schütz T; Spachos T; Ertl S; Weiss ML; Lochs H; Plauth M
    Hepatology; 2000 Dec; 32(6):1208-15. PubMed ID: 11093726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional Hassab's operation for esophagogastric varices in cirrhotic patients with resectable hepatocellular carcinoma.
    Sugo H; Fujiwara N; Yoshimoto J; Miwa K; Ishizaki Y
    Hepatogastroenterology; 2008; 55(86-87):1686-90. PubMed ID: 19102370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
    Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
    Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
    Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
    Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
    J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low pretransplant peripheral blood mononuclear cell complex I activity predicts metabolic disturbances and inability to regain fat free mass in cirrhotic patients undergoing liver transplantation.
    Briet F; Aqel BA; Jeejeebhoy KN; Scolapio JS
    Nutr Res; 2009 Jan; 29(1):26-34. PubMed ID: 19185774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease.
    Yoon SH; Choi NW; Yun SR
    Nephron Clin Pract; 2009; 111(1):c1-6. PubMed ID: 19023220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma.
    Thelen A; Jonas S; Benckert C; Weichert W; Schott E; Bötcher C; Dietz E; Wiedenmann B; Neuhaus P; Scholz A
    Ann Surg Oncol; 2009 May; 16(5):1222-30. PubMed ID: 19224279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding.
    Sempere L; Palazón JM; Sánchez-Payá J; Pascual S; de Madaria E; Poveda MJ; Carnicer F; Zapater P; Pérez-Mateo M
    Rev Esp Enferm Dig; 2009 Apr; 101(4):236-48. PubMed ID: 19492899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of concomitant gastric varices in patients with hepatocellular carcinoma at a single Japanese institute.
    Nanashima A; Sumida Y; Abo T; Shibata K; Tomoshige K; Takeshita H; Hidaka S; Fukuoka H; Mochinaga K; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2009; 56(91-92):857-60. PubMed ID: 19621717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
    Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.